More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Human Iso-Insulin ELISA
Human Iso-Insulin ELISA

Human Iso-Insulin ELISA

CE-IVD
10-1128-01
Mercodia
DownloadDatasheet
DownloadMSDS
Product group Assays
Price on request
96 wells
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Mercodia
  • Product Name
    Human Iso-Insulin ELISA
  • Delivery Days Customer
    3
  • Applications
    ELISA
  • Assay Detection Range
    3 - 100 mU/L
  • Certification
    CE-IVD
  • Scientific Description
    Mercodia Iso-Insulin ELISA provides a method for the quantitative determination of total insulin. It is a high quality enzyme immunoassay for the quantification of insulin; both endogenous and exogenous. The assay measures common, as well as non-commercially available, insulin analogues and comes with full cross-reactivity data. Combination of Mercodia Iso-Insulin ELISA with the highly specific Mercodia Insulin ELISA enables calculation of analog concentrations by subtracting endogenous insulin. Mercodia Diabetes Antigen Control (10-1134-01 (US only) or 10-1164-01) is designed to be used as a two-level control for human insulin. • Measures total insulin • Cross-reactivity with most insulin analogs • Calibrated against 1st International Reference Preparation 66/304 for human insulin. • CE/IVD labeled on select markets
  • UNSPSC
    41116133

References

  • Ramos-Rodriguez, J. J. et al. Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring. Mol. Neurodegener. 12, 57 (2017)
    Read more
  • van Dijk, P. R. et al. Different effects of intraperitoneal and subcutaneous insulin administration on the GH-IGF-1 axis in type 1 diabetes. J. Clin. Endocrinol. Metab. jc.2016-1473 (2016).
    Read more
  • Cengiz E, Swan KL, Tamborlane WV, Sherr JL, Martin M, Weinzimer SA. The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin. Diabetes Care. 2012;35(4):690-2.
    Read more
  • Cengiz E, Tamborlane WV, Martin-fredericksen M, Dziura J, Weinzimer SA. Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes. Diabetes Care. 2010;33(5):1009-12.
    Read more
  • Sintov AC, Levy HV, Botner S. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. J Control Release. 2010;148(2):168-76.
    Read more